An AI tool called REA can take apart software that isn’t meant to be opened in printers, smart TVs, cars, and more. Its ...
TikTok creator Mandy Rulez popularized the trend, which features users showing off a stack of activities designed to engage the brain and cut down on screen time. Brainstacking videos showcase ...
Sept 24 (Reuters) - A consortium backed by BlackRock (BLK.N), opens new tab and IFM Investors is in exclusive talks to buy Stack Infrastructure's Asia Pacific data center portfolio for up to $25 ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its data license agreement with Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX). Additionally, the two companies ...
There Is Something We Have to Do Right Now About A.I. Artificial intelligence labs are on the verge of handing over the training of A.I. to A.I. We should stop them. There’s a chasm right now between ...
Earlier this year, Rishub Jain left his position as an artificial intelligence researcher at Google DeepMind after a revelation. As he worked on new models, he came to believe that he and everyone ...
Young people are supposed to be the happiest among us. Increasingly, they are not. Today's epidemic of youth despair shows a departure from decades of previous research. Historically, youth and ...
There’s growing excitement in the AI industry about the idea that today’s leading models could build the next generation of the technology. But a new study recently found top AI agents struggle on the ...
Emerald AI, now valued at $1.05 billion, uses software to keep power demand at the computing facilities from getting out of control. By Sri Muppidi Silicon Valley Power is nowhere near the size of the ...
Donald Trump is now claiming that he has ordered hospitals to perform “reverse surgery” on trans people. It is not clear what he’s referring to. The president was speaking at a rally in Myrtle Beach, ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results